In brief
The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters is a nursing research record that should be interpreted using the available source metadata.
What this article is about
Quick Answer
The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters is a nursing research record that should be interpreted using the available source metadata.
Student takeaways
Key Takeaways
- The database record does not provide key finding 1.
- The database record does not provide key finding 2.
- The database record does not provide key finding 3.
- The database record does not provide key finding 4.
- The database record does not provide key finding 5.
Student summary
Why This Research Matters
This article introduces a clinical trial investigating the impact of an electronic patient decision support system, DiaPaDeSS (Diabetes Patient Decision Support System), on patients with type 2 diabetes. The primary goal is to determine if this digital tool can improve how these patients manage their condition at home and become more active in their own care.
The study focuses on several key areas: self-management, patient activation, and metabolic parameters. Self-management refers to the daily actions patients take to control their diabetes, such as monitoring blood sugar levels, checking blood pressure, tracking weight, taking medications correctly, and performing foot care. Patient activation means empowering individuals to understand their health condition, actively participate in decision-making with healthcare providers, and consistently follow through on agreed-upon treatment plans. Metabolic parameters are specific biological markers that indicate how well the body is managing diabetes; improvements here could mean better blood sugar control.
The research problem addressed by this study stems from a common challenge: after being discharged from hospital care or seeing their doctor, patients with type 2 diabetes must continue performing these important self-care tasks at home. However, maintaining consistent and effective self-management can be difficult without ongoing support. The authors suggest that increasing patient activation—making individuals feel more confident and capable in managing their health—is crucial for achieving positive outcomes like better metabolic control.
This study is designed as a single-blind, randomized controlled trial (RCT). This means participants will be randomly assigned to either the intervention group or the control group, ensuring both groups are similar at the start of the study. The 'single-blind' aspect implies that while patients might not know which group they're in, researchers assessing outcomes would be aware. For this particular research question, it is important for students to understand how RCTs work and why blinding (or lack thereof) can affect results.
The intervention involves the DiaPaDeSS system itself. The content of DiaPaDeSS includes patient education about type 2 diabetes, self-management practice tasks that patients perform daily, weekly, or quarterly, a structured program based on DiaPaDeSS algorithms for learning and applying this information, and various measurement questionnaires to assess outcomes. Before the main trial begins, there are preliminary steps: experts in medicine, nursing, and informatics will evaluate the content of DiaPaDeSS to ensure it's appropriate and effective. A feasibility test with seven patients will also be conducted to check if the system is user-friendly.
The study plans to recruit 36 participants for each group (intervention and control), totaling 72 patients. Both groups will use a version of DiaPaDeSS for three months. The intervention group will have access to all features, including comprehensive education and interactive tasks designed to build self-management skills and activation. The control group will also receive some elements like the measurement questionnaires but not the full educational content or practice tasks related to self-management.
When appraising this study as a nursing student, consider several aspects: 1. **Research Question:** Is it clear what the researchers are trying to find out? 2. **Study Design:** Why was an RCT chosen? What are its strengths and weaknesses in this context (e.g., blinding)? 3. **Intervention:** How is DiaPaDeSS described? Is it a well-defined intervention that can be replicated? 4. **Participants:** Who are the patients involved, and how were they selected? Are there any potential biases in recruitment or selection? 5. **Outcome Measures:** What specific things will be measured (self-management, activation, metabolic parameters)? How reliable and valid are these measures? 6. **Ethics & Rights:** The source record indicates it's from ClinicalTrials.gov, which is a public registry for clinical trials. This means the study has likely undergone ethical review by an Institutional Review Board (IRB) or Ethics Committee to protect participants' rights and safety. Students should understand that this ethical oversight is crucial. 7. **Source & Rights:** The record notes it's from ClinicalTrials.gov, which provides a persistent identifier (NCT05902156). This helps in verifying the study and accessing its details later. It also mentions
Source abstract
Study Overview
This study evaluates the effects of an electronic patient decision support system developed for the use of patients with type 2 diabetes (DiaPaDeSS) on self-management, patient activation, and metabolic parameters. To manage type 2 diabetes after discharge, patients must continue to perform interventions at home, such as blood glucose monitoring, blood pressure measurement, weight measurement, medication use, and foot care. To achieve this, patient's self-management and activation levels should be increased. This can also lead to positive improvements in the metabolic parameters. It would be beneficial to develop DiaPaDeSS that can increase the self-management and activation levels of patients with type 2 diabetes. The investigators will develop the DiaPaDeSS intervention protocol. Our content includes patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), a type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires. The content of the DiaPaDeSS will be evaluated by 10 experts in the fields of medicine, nursing, and informatics. A feasibility test with seven patients will be conducted to evaluate the usability of DiaPaDeSS. A single-blind, randomized controlled trial design will be used. Patients with type 2 diabetes will be pretested and randomized (intervention 36, control 36) to the DiaPaDeSS intervention and control groups. Both the DiaPaDeSS intervention and control groups will use the DiaPaDeSS for three months. While participants in the DiaPaDeSS intervention group can reach all contents of the DiaPaDeSS, others can reach only these fields: self-management practice tasks (daily, weekly, quarterly), and measurements questionnaires. The effectiveness of the DiaPaDeSS will be evaluated at baseline and at month 3.
Evidence appraisal
Main Findings
- The database record does not provide key finding 1.
- The database record does not provide key finding 2.
- The database record does not provide key finding 3.
- The database record does not provide key finding 4.
- The database record does not provide key finding 5.
Practice transfer
Clinical Relevance
- Clinical implication 1 should be interpreted cautiously because the database record is limited.
- Clinical implication 2 should be interpreted cautiously because the database record is limited.
- Clinical implication 3 should be interpreted cautiously because the database record is limited.
- Clinical implication 4 should be interpreted cautiously because the database record is limited.
- Clinical implication 5 should be interpreted cautiously because the database record is limited.
Faculty notes
Educational Relevance
The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters can be used for source-grounded discussion. The database record does not provide enough detail for a fuller faculty summary.
Critical appraisal
Limitations
- The database record does not provide limitation 1.
- The database record does not provide limitation 2.
- The database record does not provide limitation 3.
Classroom use
Discussion Questions
- Discussion question 1: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 2: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 3: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 4: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 5: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 6: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 7: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 8: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 9: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
- Discussion question 10: What does "The Effect of Electronic Patient Decision Support System Developed for Use Patients with Type 2 Diabetes (DiaPaDeSS) on Self-Management, Patient Activation and Metabolic Parameters" help nursing students evaluate?
Search-ready answers
Frequently asked questions
What is the primary goal of the DiaPaDeSS intervention protocol?
The primary goal of the DiaPaDeSS (Diabetes Patient Decision Support System) intervention protocol is to increase self-management and activation levels in patients with type 2 diabetes.
Which specific aspects of patient care does the abstract mention as important for managing type 2 diabetes after discharge?
The abstract mentions that, after discharge, patients must continue performing interventions at home such as blood glucose monitoring, blood pressure measurement, weight measurement, medication use, and foot care to manage their type 2 diabetes.
What is the study design used in this research on DiaPaDeSS?
A single-blind, randomized controlled trial (RCT) design will be used for this study.
How many participants are planned for each group in the RCT phase of the DiaPaDeSS study?
The abstract states that 36 patients with type 2 diabetes will be randomized to the DiaPaDeSS intervention group and another 36 to the control group.
What is the duration of the DiaPaDeSS intervention for participants in both groups?
Both the DiaPaDeSS intervention and control groups will use the DiaPaDeSS system for three months.
How does the access to DiaPaDeSS content differ between the intervention and control groups during the study?
Participants in the DiaPaDeSS intervention group can reach all contents of the DiaPaDeSS. Participants in the control group can only access specific fields: self-management practice tasks (daily, weekly, quarterly), and measurement questionnaires.
What are some components included within the content of the DiaPaDeSS system?
The content of the DiaPaDeSS includes patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), a type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires.
What is one step taken before the main clinical trial phase in this study?
Before the main single-blind RCT, a feasibility test with seven patients will be conducted to evaluate the usability of DiaPaDeSS. Additionally, its content was evaluated by 10 experts from medicine, nursing, and informatics.
What are the three primary outcomes that the investigators aim to evaluate regarding the effectiveness of DiaPaDeSS?
The effectiveness of DiaPaDeSS will be evaluated on self-management levels, patient activation levels, and metabolic parameters in patients with type 2 diabetes.
When is this clinical trial study expected to be published or completed according to its publication date metadata?
According to the provided source metadata, the journalName entry for ClinicalTrials.gov suggests a publicationDate of '2025-03-30' for this record. However, it's important to note that this is likely an archival date for the trial registration rather than the actual completion or publication date of findings.